eRapport

Epitranscriptomic regulation and genome stability of the fertilized egg and the preimplantation embryo.

Prosjekt
Prosjektnummer
2023035
Ansvarlig person
Arne Klungland
Institusjon
Oslo universitetssykehus HF
Prosjektkategori
Postdoktorstipend
Helsekategori
Reproductive Health and Childbirth, Generic Health Relevance
Forskningsaktivitet
1. Underpinning, 4. Detection and Diagnosis
Rapporter
2024
Pseudouridine (Ψ) is the most abundant post-transcriptional modification and is widespread in most RNA species. Several techniques have been developed to map this modification: Ψ-seq, Pseudo-seq, PSI-seq, CeU-seq, RBS-seq and BID-seq (Zhang, Dai, & He, 2023)Pseudouridine (Ψ) is condisered a key post-transcriptional modification in RNA, yet mapping of Ψ typically requires large amounts of input material. The lowest starting amount reported to date is 10 ng of polyA+ RNA using the BID-seq technique, which is still too much for mapping the Ψ in oocytes and embryos. The lowest starting amount reported to date is 10 ng of polyA+ RNA using the BID-seq technique, which is still too much for mapping the Ψ in oocytes and embryos. Recently, a sensitive picogram-scale MeRIP-seq (picoMeRIP-seq) method for m6A was demonstrated (Y. Li et al., 2024). During my postdoc period, I propose to use the picoMeRIP-seq methods to landscape the Ψ in mouse oocytes and preimplantation embryos. An overarching goal is to understand the role of Ψ during embryonic development in different species. In 2024 we have established a protocol for mapping of Pseudouridine in mRNA and other RNA-species. We are currently collecting oocytes and embryos to study the dynamics of Pseudouridine in the very early stage of life. Since such dynamics could also be key for cancerous growth, we also aim at obtaining funding for studying the role of Pseudouridine in cancer.

NO

2023
A surprisingly high proportion of fertilized mammalian eggs fail to develop to the implantation stage. The major aim of this study is define the dynamics of RNA modifications during embryo development and their role in genome stability. Here, the pseudouridine modification will be the major focus.The Post Doc candidate was recruited during autumn 2023 and therefore the progress described here is for 2 months. We are currently establishing a low-input, with the aim of single-cell input, protocol for identifying the location and dynamics of pseudoruidine in mRNA and other non-cosing RNAs. Quatitative analysis indicate that the amount of pseudouridine in mRNA is highly dynamic during embryo development as well as cancer cells. A novel mouse model (for the ALKBH4 gene/protein) , designed by the Core Facility for Transgenics, is soon completed and will be used to establish novel methods for identifying genome stability in the early embryo. The full depletion of ALKBH4 lead to arrest of the fertilized egg, thus, we have designed a mouse for inducible depletion of ALKBH5

NO

Vitenskapelige artikler
Li Y, Wang Y, Vera-Rodriguez M, Lindeman LC, Skuggen LE, Rasmussen EMK, Jermstad I, Khan S, Fosslie M, Skuland T, Indahl M, Khodeer S, Klemsdal EK, Jin KX, Dalen KT, Fedorcsak P, Greggains GD, Lerdrup M, Klungland A, Au KF, Dahl JA

Single-cell m

Nat Biotechnol 2023 Jun 22. Epub 2023 jun 22

PMID: 37349523

Deltagere
  • Xuechen Wu Doktorgradsstipendiat (annen finansiering)
  • Sonia Peña Pérez Forskningspersonell
  • Yanjiao Li Postdoktorstipendiat (annen finansiering)
  • Kangxuan Jin Forsker (annen finansiering)
  • Aylin Cengiz Doktorgradsstipendiat (annen finansiering)
  • Arne Klungland Prosjektleder
  • Dongjie Zhou Postdoktorstipendiat (finansiert av denne bevilgning)

eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT

Alle henvendelser rettes til eRapport

Personvern  -  Informasjonskapsler